Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company... see more

Bullboard (TSXV:MPH)

View:
1 2 3 4 5 6 7 8 9 10 11 12 Next
Comment by pholoveron Oct 22, 2024 1:45pm

RE:Oct 23 will be 6 months from fast track date

The share price to me, appears to be reflecting people figuring out, looking at their cash flow statement that they have not made their proper payments to Zydus for Zipitimag and are in danger of ...more  
89
Discussion
Post by Checkouton Oct 03, 2024 10:33am

Oct 23 will be 6 months from fast track date

of April 23. This is the timeline to have it finished and the potential of a 100 - 200 million pay check. Place your bets. The drug works, but maybe too well because if the children do not take it.... ...more  
187
Discussion
Comment by pholoveron Sep 22, 2024 12:33am

RE:RE:Will this be just another Bert Friesen Failure?

Very insightful post Whalewatcher.  I have heard that it has been brought to the attention of more than one Director.  Self dealing/filing patents using a related Company in this case is ...more  
108
Discussion
Post by Checkouton Sep 20, 2024 1:33pm

forgive my math

if MC1 is approved, and we sell the voucher from FDA for at least $100,000,000 with 10,000,000 shares outstanding, on paper, would that not be a ten bagger of the current share price of 1$ We have no ...more  
89
Comment by Checkouton Sep 18, 2024 2:31pm

RE:RE:April May and June gone

it fast tracked is within 6 months would it not seem silly to be labeled fast tracked and then get delayed. Odds are in our favor. Problem: Pyridox (am) ine 5'-phosphate oxidase (PNPO ...more  
57
Discussion
Comment by Checkouton Sep 18, 2024 2:23pm

RE:April May and June gone

July, Aug, Sept we are getting close to a decision from FDA.
36
Discussion
Comment by Whalewatcher1on Sep 09, 2024 10:44pm

RE:Will this be just another Bert Friesen Failure?

Hey Pholover, How does this board allow Bert to continue his self serving?  Bert’s Medicure MC-1 fails, so he uses one of his personally owned holding company to file patents on next ...more  
145
Discussion
Post by pholoveron Aug 07, 2024 11:30pm

Will this be just another Bert Friesen Failure?

His original idea with this drug for Heart Surgery just did not last long enough in the bloodstream to work. It is not likely he will fail here too? ..His whole career has been stuff that has not ...more  
311
Discussion
Post by Checkouton Jul 10, 2024 6:02pm

April May and June gone

Review Timelines: Under standard review, the FDA typically reviews a drug application in approximately ten months. With Priority Review, the FDA completes the review within six months
182
Discussion
Comment by Checkouton Jul 10, 2024 5:31pm

RE:According to case reports, treatment with PLP can prevent

if we get FDA approval we also recieve a fast track voucher worth 100 - 200 million dollars.  The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results ...more  
114
Discussion
Post by Checkouton Jul 10, 2024 5:28pm

According to case reports, treatment with PLP can prevent

 2) May Be Better for Some Forms of Vitamin B6-Dependent Seizures The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results in seizures, known as vitamin ...more  
109
Discussion
Comment by Whalewatcher1on Jun 28, 2024 10:25am

RE:New Press Release - Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

When will these selft dealings end. Go look back at the last 30 years and its just one self-dealing after the other. Bert's gotten rich, while there isnt a single company that investors did well ...more  
140
Discussion
Comment by Whalewatcher1on Jun 28, 2024 10:22am

RE:we are led by greatness

HaHa!  This and other awards are all paid. For like $10k these magazines will profile you. Only those with MASSIVE ego's would pay. Go to their website and look at the list of paid awards . . ...more  
90
Discussion
Comment by pholoveron Jun 24, 2024 8:55pm

RE:Someone tell me the odds are not in our favor.

This "worries" me that Friesen is taking more money from MPH to his Company.  This guy strips all the cash and then if things work out, great if not, he still gets hundreds of thousands ...more  
118
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities